Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
-
19601
Relative diver effects – fixed distance and 5 minute waiting period.
Published 2011“…<p>Relative diver effects on estimated reef fish densities comparing counts over a fixed distance 50 m transect and counts after a 5 minute waiting period. …”
-
19602
-
19603
Fig 2 -
Published 2020“…<b>B: Boxplots of HbA1c comparing α-thalassemia status.</b> In participants with G6PD deficiency, 8/24 (32.3%) hemizygous males, 1/4 (25.0%) homozygous female, and 15/40 (37.5%) heterozygous females had PD/DM by HbA1c, compared to 176/363 (48.5%) of those with no G6PD deficiency (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0244782#pone.0244782.t003" target="_blank">Table 3</a>). …”
-
19604
-
19605
Fig 3 -
Published 2020“…</b> By OGTT, PD/DM was prevalent in 32/52 (61.5%) of participants with homozygous α<sup>+</sup> AT, 90/186 (48.4%) of those with heterozygous α<sup>+</sup> AT, and 89/193 (46.1%) of those without α-thalassemia (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0244782#pone.0244782.t003" target="_blank">Table 3</a>). …”
-
19606
-
19607
-
19608
Table1_Effects of physical activity on the severity of illness and mortality in COVID-19 patients: A systematic review and meta-analysis.docx
Published 2022“…Subgroup analysis showed that PA for ≥150 min/wk at a moderate intensity or ≥75 min/wk at a vigorous intensity reduced the risks of severity and mortality. …”
-
19609
Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis
Published 2019“…Bayesian outcome probabilities (P) of an OR<1 were calculated, and values of at least 90% (0.9) were deemed to indicate a significant result.</p><p>Results</p><p>Among the 6,249 identified publications, 48 studies were eligible for the meta-analysis, including 2 randomized controlled trials, 41 cohort studies, and 5 case-control studies. …”
-
19610
-
19611
-
19612
-
19613
Relative quantification comparisons of SP-A1 (A), SP-A2 (B), and SP-D (C) in ULTR treated with 5, 10 and 20 μg/ml of rhSPD after 6 and 12h (*p<0.05, **p<0.01, ***p<0.001).
Published 2015“…<p>rhSP-D treatments resulted in an increase of SP-A1, SP-A2 and SP-D mRNA expression at 6 h at 5 and 10 μg/ml. …”
-
19614
-
19615
-
19616
Indoxyl sulfate modulates FNDC5 expression in skeletal muscle cells.
Published 2013“…<p>A, Dose-response relationship for the decrease in FNDC5 expression in skeletal muscle cells treated with indoxyl sulfate for 24 h. …”
-
19617
-
19618
A Comprehensive Study of Extended Tetrathiafulvalene Cruciform Molecules for Molecular Electronics: Synthesis and Electrical Transport Measurements
Published 2014“…The molecules were subjected to a comprehensive study of their conducting properties as well as their photophysical and electrochemical properties in solution. …”
-
19619
Image_4_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png
Published 2021“…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”
-
19620
Image_6_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png
Published 2021“…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”